MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and ...

MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology ...

Sight Sciences, Inc. ( (SGHT)) has released its Q3 earnings. Here is a breakdown of the information Sight Sciences, Inc. presented to its investors. Sight Sciences, Inc. is an eyecare technology ...

The analysis published in Clinical Ophthalmology suggests that OMNI was as effective at lowering IOP and reducing medication usage in advanced glaucoma as it was in mild and moderate glaucoma. MENLO ...

4 analysts have shared their evaluations of Sight Sciences (NASDAQ:SGHT) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...

MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing ...

UBS raised the firm’s price target on Sight Sciences (SGHT) to $12 from $7 and keeps a Buy rating on the shares. Medicare Administrative Contractors Novitas and First Coast Service Option established ...